Continued Expansion Forecast for Telemedicine, RPM Markets

The telemedicine and remote patient monitoring (RPM) market has expanded significantly in recent years due to the COVID-19 pandemic and need for remote healthcare delivery. This growth is expected to continue in the near future, with the RPM devices sector set to reach an estimated $1.2 billion by 2025, and the telemedicine market projected to top $185 billion by 2026, according to GlobalData. 
 
RPM devices allow healthcare providers to monitor patients’ health metrics from a distance. This technology provides early detection of health problems and can prevent unnecessary hospital visits, making it an attractive option for both patients and providers.
 
“Artificial intelligence (AI) is also being integrated into telemedicine and RPM, enabling providers to analyze data from remote monitoring devices and gain valuable insights into patient health. This technology has the potential to significantly improve patient outcomes and reduce healthcare costs,” GlobalData Medical Devices Analyst Cynthia Stinchcombe said. 
 
In addition to these developments, telemedicine is becoming more accessible to patients. Virtual consultations allow patients to connect with their healthcare providers from anywhere, and market growth is being driven by the convenience and cost-effectiveness of virtual visits as well as the availability of high-speed internet and mobile devices.
 
“The expansion of telemedicine and RPM is expected to continue in the coming years, as these technologies become increasingly vital to the healthcare industry,” Stinchcombe noted. “With the ongoing COVID-19 pandemic and the growing demand for virtual healthcare, telemedicine and RPM are poised to play a critical role in delivering healthcare services to patients around the world.”